PatrickHPetersJr.MD

Research History

• A Phase III, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous XXXX in Subjects with Uncomplicated Acute Influenza2012 - Present
• Phase IIIb - A Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with XXX in Addition to Standard of Care in Subjects with Type 2 Diabetes and Acute Coronary Syndrome.2012 - Present
• Phase III – An Open-Label 52 week Study to Assess the Long-Term Safety of NKTR-118 in Opioid-Induced Constipation (OIC) in Patients with Non-Cancer-Related Pain2012 - Present
• 2011 Phase III – A randomized, double-blind, placebo-controlled, event-driven trial of quarterly subcutaneous canakinumab in the prevention of recurrent cardiovascular events among stable post-myocardial infarction patients with elevated hsCRP2012 - Present
• Phase IIIb - A Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with XXX in Addition to Standard of Care in Subjects with Type 2 Diabetes and Acute Coronary Syndrome.2011 - Present
• Phase III – A Randomized-Withdrawal, Placebo-Controlled, Study Evaluating the Efficacy, Safety and Tolerability, of XXXX Extended-Release (ER) in Subjects with Chronic, Painful Diabetic Peripheral Neuropathy (DPN)2010 - 2010
• Phase III – A Phase 3, Randomized, Double-blind, Double-dummy, Parallel Group, Muti-Center, Multi-National Study for Evaluation of Efficacy and Safety of XXXX Versus Warfarin in Subjects with Atrial Fibrillation – Effective aNticoaGulation with Factor xA2010 - 2010
• Phase IIIb – A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with XXXX in Addition to Standard of Care in Subjects with Type 2 Diabetes and Acute Coronary Syndrome2010 - 2010